Belgium· BE-AMP-SAM593377-00
Methoxsalen Macopharma 20 µg/ml
A other immunostimulants product containing methoxsalen, registered in Belgium by Maco Pharma. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Methoxsalen is registered in 8 of 19 countries.
Countries holding a registration under ATC L03AX (other immunostimulants), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Methoxsalen · ATC L03AX
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Methoxsalen
- Manufacturer
- Maco Pharma
- Country
- Belgium (BE)
- ATC code
- L03AX
- ATC class
- Other immunostimulants
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4891537
- be_apb7742331
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methoxsalen in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainMETOXALENO G.L. PHARMA 20 MICROGRAMOS/ML SOLUCION PARA MODIFICACION DE LAS FRACCIONES SANGUINEASG.L. Pharma Gmbh
- CzechiaMETHOXSALEN MACO PHARMAMACO PHARMA, Mouvaux
- NorwayUvadexTherakos Europe Ltd
- SwedenUvadex 20 mikrogram/ml Lösning för modifiering av blodfraktionTherakos Europe Limited
- United Kingdom8-Methoxypsoralen 0.005% gelSpecial Order
- FranceMELADININE 0,1 POUR CENT, solution pour application localeMITEM PHARMA
- Japanメトキサレン大正製薬
- GermanyMethoxsalen G.L. PharmaG.L. Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Methoxsalen Macopharma, Methoxsalen S.A.L.F.
- Czechia · Methoxsalen Maco Pharma, Uvadex
- Germany · Methoxsalen G.L. Pharma, Methoxsalen Macopharma
- Denmark · Methoxsalen Macopharma, Uvadex
- Spain · Metoxaleno G. L. Pharma, Metoxaleno Macopharma
- France · Meladinine, Methoxsalene G.L. Pharma
- United Kingdom (Northern Ireland) · Methoxsalen G.L. Pharma, Uvadex
- Greece · Melaoline
- Hungary · Methoxsalen Macopharma, Uvadex
- Italy · Metoxsalene G.L. Pharma, Metoxsalene S.A.L.F.
- Netherlands · Uvadex
- Norway · Uvadex
- Poland · Uvadex
- Portugal · Uvadex
- Sweden · Uvadex
- Slovenia · Metoksalen Maco Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1b3a812-39e3-4c9b-9f3b-05b756f1cff1 GET /v1/drugs/c1b3a812-39e3-4c9b-9f3b-05b756f1cff1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for blood fraction modification",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Methoxsalen Macopharma 20 µg/ml",
"name_fr": "Methoxsalen Macopharma 20 µg/ml",
"name_nl": "Methoxsalen Macopharma 20 µg/ml",
"amp_code": "SAM593377-00",
"strengths": [
"0.0200",
"0.0200",
"2.0800",
"9.0000"
],
"pack_count": 1,
"substances": [
"Methoxsalen",
"Ethanol",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Other Immunostimulants",
"authorisation_numbers": [
"BE593377"
]
}See everything about methoxsalen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.